Sanofi, Regeneron hustle Kevzara into second pivotal coronavirus study

30th March 2020 Uncategorised 0

In the hunt for a COVID-19 treatment, Sanofi and Regeneron have thrown their shared IL-6 inhibitor Kevzara into the global effort. After trumpeting its plan to enroll U.S. patients in a late-stage repurposing trial, the partners have now launched a matching study outside the U.S.

More: Sanofi, Regeneron hustle Kevzara into second pivotal coronavirus study
Source: fierce